rs652285

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_181351.5(NCAM1):​c.1825+1318G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0578 in 152,198 control chromosomes in the GnomAD database, including 366 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.058 ( 366 hom., cov: 32)

Consequence

NCAM1
NM_181351.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.195

Publications

3 publications found
Variant links:
Genes affected
NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NCAM1NM_181351.5 linkc.1825+1318G>A intron_variant Intron 14 of 19 ENST00000316851.12 NP_851996.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NCAM1ENST00000316851.12 linkc.1825+1318G>A intron_variant Intron 14 of 19 5 NM_181351.5 ENSP00000318472.8

Frequencies

GnomAD3 genomes
AF:
0.0578
AC:
8786
AN:
152080
Hom.:
367
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.102
Gnomad AMI
AF:
0.0352
Gnomad AMR
AF:
0.0461
Gnomad ASJ
AF:
0.0550
Gnomad EAS
AF:
0.116
Gnomad SAS
AF:
0.0280
Gnomad FIN
AF:
0.0229
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0369
Gnomad OTH
AF:
0.0478
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0578
AC:
8791
AN:
152198
Hom.:
366
Cov.:
32
AF XY:
0.0571
AC XY:
4248
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.102
AC:
4251
AN:
41512
American (AMR)
AF:
0.0461
AC:
706
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0550
AC:
191
AN:
3470
East Asian (EAS)
AF:
0.116
AC:
602
AN:
5170
South Asian (SAS)
AF:
0.0278
AC:
134
AN:
4826
European-Finnish (FIN)
AF:
0.0229
AC:
243
AN:
10606
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0369
AC:
2511
AN:
68000
Other (OTH)
AF:
0.0473
AC:
100
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
412
824
1235
1647
2059
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0431
Hom.:
431
Bravo
AF:
0.0620
Asia WGS
AF:
0.0600
AC:
210
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
13
DANN
Benign
0.71
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs652285; hg19: chr11-113107204; COSMIC: COSV57522513; COSMIC: COSV57522513; API